Medifast (MED) Total Liabilities (2010 - 2026)

Medifast (MED) has 17 years of Total Liabilities data on file, last reported at $54.4 million in Q1 2026.

• For the quarter ending Q1 2026, Total Liabilities fell 21.27% year-over-year to $54.4 million; the trailing twelve-month figure through Mar 2026 stood at $54.4 million (down 21.27% YoY), and the FY2025 full-year result was $49.1 million, down 33.81% from the prior year.
• Total Liabilities for Q1 2026 stood at $54.4 million, up from $49.1 million in the prior quarter.
• Across five years, Total Liabilities topped out at $211.1 million in Q2 2022 and bottomed at $49.1 million in Q4 2025.
• The 5-year median for Total Liabilities is $91.8 million (2024), against an average of $111.2 million.
• The widest annual swing landed in 2022, when Total Liabilities surged 35.58%; it then slumped 39.57% in 2025.
• A 5-year view of Total Liabilities shows it stood at $161.2 million in 2022, then plunged by 32.72% to $108.4 million in 2023, then tumbled by 31.66% to $74.1 million in 2024, then plunged by 33.81% to $49.1 million in 2025, then rose by 10.83% to $54.4 million in 2026.
• The last three Total Liabilities figures came in at $54.4 million (Q1 2026), $49.1 million (Q4 2025), and $53.5 million (Q3 2025), per Business Quant data.

Peer Comparison